NDC 63323-578 – Glycopyrrolate

Glycopyrrolate .2 mg/mL · Injection, Solution · Intramuscular, Intravenous

Human Prescription Drug 1 recall

Product NDC63323-578

Product details

Brand name
Glycopyrrolate
Generic name
Glycopyrrolate
Labeler
Fresenius Kabi USA, LLC
Dosage form
Injection, Solution
Route
Intramuscular, Intravenous
Marketing category
ANDA · ANDA209328
Marketed since
October 27, 2017
Listing expires
December 31, 2026
Pharmacologic class
Anticholinergic

Active ingredients

Uses, dosage, side effects and warnings for Glycopyrrolate →

Package NDC codes (5)

Package NDCDescriptionSince
63323-578-0125 VIAL, SINGLE-DOSE in 1 CARTON (63323-578-01) / 1 mL in 1 VIAL, SINGLE-DOSE (63323-578-03)Oct 27, 2017
63323-578-0225 VIAL, SINGLE-DOSE in 1 CARTON (63323-578-02) / 2 mL in 1 VIAL, SINGLE-DOSE (63323-578-04)Oct 27, 2017
63323-578-0525 VIAL, MULTI-DOSE in 1 CARTON (63323-578-05) / 5 mL in 1 VIAL, MULTI-DOSE (63323-578-07)Oct 27, 2017
63323-578-1125 VIAL, SINGLE-DOSE in 1 CARTON (63323-578-11) / 1 mL in 1 VIAL, SINGLE-DOSE (63323-578-41)Oct 27, 2017
63323-578-1225 VIAL, SINGLE-DOSE in 1 CARTON (63323-578-12) / 2 mL in 1 VIAL, SINGLE-DOSE (63323-578-42)Oct 27, 2017

Recalls mentioning this NDC

Other Glycopyrrolate products